About Bikanta

Bikanta is introducing a revolutionary platform nanotechnology based on nanodiamonds to push the boundaries of current optical imaging methods for medical diagnostics. The potential of nanotechnology in the near-term is to act as tools to study disease. The long-term impact of nanomedicine will be the story of extending surgical control to the cellular level.

Company Highlights
Year Founded

2013

icon-altEmployees

4

Location (HQ)

USA

Since Last Funding

10 years

Monthly Website Visitors

1.8K

icon-altTotal Investment Amt

$1.7M

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Health Diagnostics

Biotechnology Research

Nanotechnology